We are live on ! Find out more
DC

Davenport & Co Portfolio holdings

AUM $20.4B
1-Year Est. Return 18.11%
This Fund
S&P 500
This Quarter Est. Return
+0.23%
1 Year Est. Return
+18.11%
3 Year Est. Return
+63.26%
5 Year Est. Return
+74.4%
10 Year Est. Return
+287.26%
AUM
$17.7B
AUM Growth
+$60.4M
Cap. Flow
+$209M
Cap. Flow %
1.18%
Top 10 Hldgs %
18.86%
Holding
1,213
New
72
Increased
562
Reduced
438
Closed
64

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$59.8M
2
NVO
Novo Nordisk
NVO
+$48.8M
3
UNH icon
UnitedHealth
UNH
+$46.4M
4
UBER icon
Uber
UBER
+$37M
5
SNY icon
Sanofi
SNY
+$33.8M

Sector Composition

Rank Sector Weight
1 Financials 16.48%
2 Technology 15.4%
3 Healthcare 11.21%
4 Consumer Discretionary 9.96%
5 Industrials 9.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IYF icon
501
iShares US Financials ETF
IYF
$4.67B
$1.84M 0.01%
16,643
-110
-0.7% -$12.3K
IYJ icon
502
iShares US Industrials ETF
IYJ
$1.98B
$1.81M 0.01%
13,584
-114
-0.8% -$15.7K
CAKE icon
503
Cheesecake Factory
CAKE
$5.04B
$1.81M 0.01%
38,183
-2,149
-5% -$98.9K
CHWY icon
504
Chewy
CHWY
$9.25B
$1.79M 0.01%
53,381
-5,886
-10% -$183K
DAR icon
505
Darling Ingredients
DAR
$9.64B
$1.79M 0.01%
53,000
+10,700
+25% +$404K
HLMN icon
506
Hillman Solutions
HLMN
$1.54B
$1.78M 0.01%
182,667
-8,649
-5% -$92.5K
BATRK icon
507
Atlanta Braves Holdings Series B
BATRK
$3.26B
$1.78M 0.01%
46,489
-1,225
-3% -$48.8K
RECS icon
508
Columbia Research Enhanced Core ETF
RECS
$5.85B
$1.74M 0.01%
50,150
+35,636
+246% +$1.25M
NEM icon
509
Newmont
NEM
$98.7B
$1.73M 0.01%
46,449
-331,706
-88% -$15.1M
LDOS icon
510
Leidos
LDOS
$14.5B
$1.72M 0.01%
12,020
+9,212
+328% +$1.53M
SEIC icon
511
SEI Investments
SEIC
$12.4B
$1.71M 0.01%
20,777
+15
+0.1% +$1.18K
USHY icon
512
iShares Broad USD High Yield Corporate Bond ETF
USHY
$29.3B
$1.71M 0.01%
46,509
+18,008
+63% +$670K
DWLD icon
513
Davis Select Worldwide ETF
DWLD
$608M
$1.7M 0.01%
46,870
-2,396
-5% -$91.6K
PRU icon
514
Prudential Financial
PRU
$42.4B
$1.7M 0.01%
14,313
-582
-4% -$71.9K
CLX icon
515
Clorox
CLX
$11.6B
$1.69M 0.01%
10,399
-984
-9% -$161K
USFD icon
516
US Foods
USFD
$22.2B
$1.67M 0.01%
24,809
-2,327
-9% -$153K
LRCX icon
517
Lam Research
LRCX
$367B
$1.67M 0.01%
23,152
-318
-1% -$24.1K
SIRI icon
518
SiriusXM
SIRI
$9.98B
$1.67M 0.01%
73,038
-1,976
-3% -$50.4K
KKR icon
519
KKR & Co
KKR
$91.1B
$1.66M 0.01%
11,247
+14
+0.1% +$2.05K
INFL icon
520
Horizon Kinetics Inflation Beneficiaries ETF
INFL
$1.51B
$1.66M 0.01%
43,623
+3,155
+8% +$126K
SCZ icon
521
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.4B
$1.65M 0.01%
27,161
-1,124
-4% -$71.5K
CM icon
522
Canadian Imperial Bank of Commerce
CM
$108B
$1.65M 0.01%
26,067
-23,091
-47% -$1.47M
HYLS icon
523
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
$1.61B
$1.65M 0.01%
39,821
+702
+2% +$29.3K
SMG icon
524
ScottsMiracle-Gro
SMG
$3.82B
$1.62M 0.01%
24,456
+2,162
+10% +$171K
NUE icon
525
Nucor
NUE
$58.6B
$1.62M 0.01%
13,859
-939
-6% -$135K

Similar funds

Davenport & Co's Q4 2024 Portfolio in Review

As of Q4 2024, Davenport & Co held 1,213 positions worth $17.7B, up 0.34% from $17.6B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Davenport & Co's Q4 2024 filing shows 72 new, 562 increased, 438 reduced and 64 closed positions. Its largest new stake was Kirby Corp: 155,000 shares worth $16.4M. The largest sale was Walt Disney, an estimated $186M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Davenport & Co's largest Q4 2024 buy was Kirby Corp: 155,000 shares worth $16.4M.
  • Davenport & Co added most to Merck in Q4 2024, an estimated $59.8M increase.
  • Davenport & Co's biggest Q4 2024 reduction was Walt Disney, cutting an estimated $186M.
  • Davenport & Co fully exited Crown Holdings in Q4 2024, selling an estimated $2.69M.
  • Davenport & Co's ten largest holdings make up 19% of its $17.7B portfolio in Q4 2024.
  • Davenport & Co opened 72 new positions and closed 64 in Q4 2024.
  • Davenport & Co's portfolio value rose 0.34% quarter-over-quarter to $17.7B.

Based on Davenport & Co's 13F filing for Q4 2024, filed 24 Jan 2025.